First Trust NYSE Arca Biotechnology Index Fund
257 hedge funds and large institutions have $635M invested in First Trust NYSE Arca Biotechnology Index Fund in 2023 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 52 increasing their positions, 99 reducing their positions, and 22 closing their positions.
91% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 22
7% more funds holding
Funds holding: 241 → 257 (+16)
2% less capital invested
Capital invested by funds: $645M → $635M (-$9.89M)
2.13% less ownership
Funds ownership: 53.72% → 51.58% (-2.1%)
47% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 99
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$26.5M |
| 2 |
Morgan Stanley
New York
|
+$8M |
| 3 |
AAS
Ameritas Advisory Services
Lincoln,
Nebraska
|
+$6.8M |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$4.06M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOS
Silver Oak Securities
Jackson,
Tennessee
|
-$61.4M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$8.56M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$7.33M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.62M |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$4.78M |
FBT Hedge Fund Activity: Q4 2023 in Review
257 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q4 2023, worth a combined $635M — down 1.5% from $645M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new FBT positions and 22 closed out — a net gain of 20 holders — while 52 added to existing stakes and 99 trimmed.
The largest buyer was International Assets Investment Management, opening a new position worth an estimated $26.5M. The largest seller was Silver Oak Securities, cutting an estimated $61.4M.
- 257 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q4 2023, up from 241 in Q3 2023.
- Funds reported $635M of First Trust NYSE Arca Biotechnology Index Fund stock for Q4 2023, down 1.5% quarter-over-quarter.
- 42 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q4 2023 and 22 closed out, a net change of +20 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q4 2023 was International Assets Investment Management, an estimated $26.5M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q4 2023 was Silver Oak Securities, an estimated $61.4M sold.
Based on aggregated 13F filings for Q4 2023.